Neurogesx's P2P Acquisition

Neurogesx raised a round of funding on April 17, 2013. Investors include Acorda Therapeutics.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neura…

Articles about Neurogesx's P2P Acquisition: